CHA ÀǰúÇдëÇб³ Â÷º´¿ø professor

±³¼ö´Ô»çÁø
  • À̼±È£
  • ¼Ò ¼Ó: ºÐ´çÂ÷¿©¼ºº´¿ø
  • Àü¹®ºÐ¾ß : ¼Ò¾ÆÀÀ±Þ
  • Á÷ À§: ºñ°ø°³
  • ¸Þ ÀÏ: ºñ°ø°³
  • Àü È­: 1577-4488
  • ÆÑ ½º:
  • ÁÖ ¼Ò: °æ±âµµ ¼º³²½Ã ºÐ´ç±¸ ¾ßžµ¿ 351¹øÁö
  • ȨÆäÀÌÁö:
  • ·Î±×ÀÎ

ÅǸ޴º

ÁÖ¿ä¹ßÇ¥³í¹®

ÁÖ¿ä¹ßÇ¥³í¹®
¹øÈ£ ±¸ºÐ Á¦¸ñ
47 (±¹³»)KCI ¼Ò¾Æ ¸¸¼º º¹ÅëÀÇ Áø´ÜÀû Æò°¡
46 (±¹¿Ü)SCI The role of a whole blood interferon-¥ã assay for the detection of latent tuberculosis infection in Bacille Calmette?Gu?in vaccinated children
45 (±¹³»)SCOPUS ¼Ò¾Æ Àẹ °áÇÙ °¨¿° Áø´Ü¿¡ À־ Åõº£¸£Ä𸰠ÇǺιÝÀÀ °Ë»ç¿Í °áÇ٠ƯÀÌÇ׿ø ÀÚ±Ø Interferon-¥ã ºÐºñ´É ÃøÁ¤ÀÇ ºñ±³
44 (±¹³»)KCI ¼Ò¾ÆÀÇ ±âµµ Æó¼â Æò°¡¿¡¼­ impulse oscillometry system°ú ÆóȰ·® ÃøÁ¤¹ýÀÇ ºñ±³
43 (±¹³»)KCI Áý¸ÕÁö Áøµå±â Ç׿øÀ» ÀÌ¿ëÇÑ Ãʱ޼Ӹ鿪ġ·áÀÇ ¾ÈÀü¼º°ú È¿°ú
42 (±¹³»)SCI Low-dose Methotrexate Therapy for Intravenous Immunoglobulin-resistant Kawasaki Disease
41 (±¹¿Ü)SCI Prevalence and patterns of anti-nuclear antibodies in Korean children with juvenile idiopathic arthritis according to ILAR criteria
40 (±¹³»)KCIÈĺ¸ û¼Ò³â±âÀÇ ³»ºÐºñÇÐÀû Ư¡
39 (±¹³»)SCOPUS ÁßÀÌ¿° ȯ¾ÆÀÇ ÀÌ·ç¿¡¼­ ºÐ¸®µÈ Æó±¸±ÕÀÇ Ç÷ûÇü ºÐÆ÷(2001-2006)
38 (±¹³»)SCOPUS ´ÜÀϱâ°ü¿¡¼­ Á¶»çÇÑ ¼Ò¾Æ ³ú³ó¾çÀÇ ÀÓ»ó¾ç»ó(1997-2006)
ÀÌÀüÆäÀÌÁö À̵¿ 31 32 33 34 35 36 37 38 39 ´ÙÀ½ÆäÀÌÁö À̵¿
Copyright ¨Ï chamc, All rights reserved.

ºü¸£°í Æí¸®ÇÑ ÀÎÅÍ³Ý Áø·á¿¹¾à

  • °­³²Â÷º´¿ø
  • ºÐ´çÂ÷º´¿ø
  • ºÐ´çÂ÷¿©¼ºº´¿ø
  • ±¸¹ÌÂ÷º´¿ø
  • ¿©¼ºÀÇÇבּ¸¼Ò
  • Â÷¿ò

ÀüÈ­¹®ÀÇ

  • °­³²Â÷º´¿ø 02.3468.3000
  • ºÐ´çÂ÷º´¿ø 031.780.5000
  • Â÷¿ò 02.3015.5300
  • ±¸¹ÌÂ÷º´¿ø 054.450.9700
  • ´ë±¸¿©¼ºÂ÷º´¿ø 02.222.4200
  • °­³²°ÇÁø¼¾ÅÍ 02.2191.3900
  • ºÐ´çÁ¾Çհǰ­ÁõÁø¼¾ÅÍ 031.780.5940
  • ½ºÆ÷·º½º °ÇÁø¼¾ÅÍ 02.3473.2111
  • ±¸¹ÌÂ÷º´¿ø°ÇÁø¼¾ÅÍ 054.450.9800
  • ȨÆäÀÌÁö°ü¸®ÀÚ 031.780.1729